TW201221153A - Dental care product - Google Patents

Dental care product Download PDF

Info

Publication number
TW201221153A
TW201221153A TW100101362A TW100101362A TW201221153A TW 201221153 A TW201221153 A TW 201221153A TW 100101362 A TW100101362 A TW 100101362A TW 100101362 A TW100101362 A TW 100101362A TW 201221153 A TW201221153 A TW 201221153A
Authority
TW
Taiwan
Prior art keywords
block
care product
diionic
health care
electrical property
Prior art date
Application number
TW100101362A
Other languages
Chinese (zh)
Other versions
TWI428150B (en
Inventor
Yung Chang
Yu-Ju Shih
Bor-Shiunn Lee
Ruoh-Chyu Ruaan
Da-Ming Wang
Juin-Yih Lai
Original Assignee
Univ Chung Yuan Christian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chung Yuan Christian filed Critical Univ Chung Yuan Christian
Publication of TW201221153A publication Critical patent/TW201221153A/en
Application granted granted Critical
Publication of TWI428150B publication Critical patent/TWI428150B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/90Block copolymers
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N41/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
    • A01N41/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
    • A01N41/04Sulfonic acids; Derivatives thereof
    • A01N41/08Sulfonic acid halides; alpha-Hydroxy-sulfonic acids; Amino-sulfonic acids; Thiosulfonic acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5424Polymers characterized by specific structures/properties characterized by the charge anionic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426Polymers characterized by specific structures/properties characterized by the charge cationic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54Polymers characterized by specific structures/properties
    • A61K2800/542Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5428Polymers characterized by specific structures/properties characterized by the charge amphoteric or zwitterionic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/594Mixtures of polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88Two- or multipart kits
    • A61K2800/884Sequential application

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A dental care product comprises an orally acceptable carrier or excipient, and a bacterial resistance copolymer, which comprises a zwitterionic block and a charged anchoring block, wherein the anchoring block binds to tooth surfaces by electrostatic attraction, and the zwitterionic block extends outwardly to reduce the attachment of bacteria to tooth surfaces.

Description

201221153 六、發明說明: 【發明所屬之技術領域】 [0001] 本發明係關於具有高度抗牙菌效果的牙齒保健產品。 [0002] * 〇 本發明係美國專利申請案,申請號1 2/953, 036,申請 日 2010年 11 月 23 日,題為「Dental care product」 :美國專利申請案,申請號12/952, 91 3,申請曰2010年 11 月 23 日,題為「Surface anti-biomolecule agent」;以及,美國專利申請案,申請號12/953, 110 ,申請日2010年11月23日,題為「Biocarrier and method of using the same」的相關申請案,這些相 關申請案的全文皆併入本文,視為本案說明書的一部分 〇 [0003] ❹ [先前技術] 多數人患有蛀牙。造成蛀牙的原因有幾個因素。醫界 普遍認為牙菌斑(dental piaqu.e)是造成牙齒姓壞的主 要原因。牙菌斑是一種通常無色的生物薄膜(biofilm) ,由在牙齒上所繁殖的細菌、沉積的唾液蛋白質,與食 物殘渣等形成。牙菌斑會造成牙結石(dental calculus) 、 齒銀炎(gingivitis) , 與其他的齒銀疾病 。此 外,在牙菌斑中,轉糖鏈球菌(Streptococcus mutans)會將糖轉換成有機酸,其會在牙齒琺瑯質表面下 釋放氫離子,使琺瑯質擴散出鈣離子與磷酸鹽離子,造 成垃牙。 [0004] 用於消除口腔異味與殺菌的牙齒保健產品,例如漱口 水、牙膏、牙粉等,已經被使用超過一百年。一些抗菌 100101362 表單編號A0101 第3頁/共35頁 1002002410-0 201221153 漱口水’例如李施德林(L i s t er i ne® ),利用精油 (essential oils)如麝香草酚(thymol)、曱基水楊酸 (methyl salicylate) ' 薄荷醇(menthol) ’ 與桉葉醇 (eucalyptol)等等作為有效成分(active ingredient) 。 另外’ 漱口水通常利用酒精 (&1(:〇1]〇1)作為有效 成分的溶劑、利用界面活性劑溶解精油與/或其他成分。 另外,其他有效的抗微生物劑,例如十六燒基氣化桃咬 (cetyl pyridinum chloride,CPC)、葡萄糖酸氯己 定(chlorhexidine gluconate)、過氧化氫 (hydrogen peroxide)、苯甲酸(benzoic acid)、酚 類化合物(phenolic compounds),與氟化物 (fluorides)等也經常被作為漱口水的主要成分。 [0005] [0006] [0007] 100101362 研究發現,上述許多有效成分會因為界面活性劑的存 在使效果打折,而一些成分則可能會傷害人體。因此, 在本領域有需要發展出更耷全、更有效的牙齒保健產品 . .... ... 〇 :;匕 V : 【發明内容】 本發明係關於具有高度抗牙菌效果的牙齒保健產品。 本發明一實施例提供一種牙齒保健產品,包含一口腔 可接受的載體或輔藥,以及一濃度在01 mg/ml以上的 一第一抗菌共聚物。抗菌共聚物包含一雙離子性嵌段與 -具有第-電性的繫住嵌段,其中該繫住喪段藉由靜電 吸引力與一牙齒表面結合,該雙離子性嵌段向外延伸, 以減少細菌附著於該牙齒表面。 ,發明另一實施例提供一種兩劑型的牙齒保健產品, 1002002410-0 表早編就A0101 第4頁/共35頁 [0008] 201221153 包含第一劑與第二劑。第一劑包含一口腔可接受的第一 載體或輔藥,以及一濃度在0.1 mg/ml以上的一第一抗 菌共聚物,其包含一第一雙離子性嵌段與一具有第一電 性的第一繫住嵌段,其中該第一繫住嵌段藉由靜電吸引 力與一牙齒表面結合,該第一雙離子性嵌段向外延伸, 以減少細菌附著於該牙齒表面。第二劑包含一口腔可接 受的第二載體或輔藥,以及一濃度在〇1 mg/ml以上的 一第二抗菌共聚物’其包含一第二雙離子性嵌段與一具 Ο 有第二電性的第二繫住嵌段,其中該第二電性與該第一 電性的電性相反,該第二繫住舞段藉由靜電吸引力與該 牙齒表面結合,該第二雙離子性嵌段向外延伸以減少 細菌附著於該牙齒表面。 【實施方式】 [0009] 以下將詳述本案的各實施例,並配合圖式作為例示。 Ο 除了這些詳細描述之外,本發明還可以廣泛地施行在其 他的實施例中,任何所述實施例的輕易替代、修改、等 效變化都包含在本案的範圍内,並以之後的專利範圍為 準。在說明書的描述卜為了使讀者對本發财較完整 、* 1,热而,本發明可能在省 略部分或全部這純定細節㈣提下,仍可實施。此外 ’幕所周知的步驟或元件並未描述於細節中,以避免造 成本發明不必要之限制;除非 r錢別限制,否則本發明 各7C件的數置可多於或少於 [0010] 口腔細菌是造成口臭 並導致牙齒與齒齦疾病 牙結石、牙菌斑的主要原因, 傳統的牙齒保健產品利用精油 100101362 表單編號A0101 第5頁/共35頁 201221153 或抗菌劑消滅細菌。與習知技術不同的是,本發明提供 的牙齒保健產品具有超高的抗牙菌效果,並且,令人驚 訝的是,此驚人的效果,可以在不使用傳統抗菌劑或精 油的條件下達成。另外,本發明實施例提供的牙齒保健 產品不會對人類造成危害。 [0011] 本發明的一實施例提供一種牙齒保健產品,其至少包 含一口腔可接受的載體(carrier)或輔藥(excipient) ,以及一濃度在0.1 mg/mL以上的抗菌共聚物 (bacterial resistance copolymer) 5 其中抗菌共 聚物被作為主要成分。 [0012] 上述抗菌共聚物包含一雙離子性板段(zwitterionic block)與一具有第一電性的繫住喪段(anchoring block)。在本實施例,繫住嵌段可帶有正電或負電,亦 即,第一電性可以是正電或負電。繫住嵌段本質上由帶 正電的單體,或帶負電的單體構威。其中,帶正電的單 體可選自下列族群的其中之一或其组合: 100101362201221153 VI. Description of the Invention: [Technical Field to Which the Invention Is Applicable] [0001] The present invention relates to a dental health care product having a highly antibacterial effect. [0002] * The present invention is a U.S. Patent Application Serial No. 1 2/953, 036, filed on November 23, 2010, entitled "Dental care product": U.S. Patent Application, Application No. 12/952, 91 3. Application 11 November 23, 2010, entitled “Surface anti-biomolecule agent”; and, US Patent Application, Application No. 12/953, 110, Application Date November 23, 2010, entitled “Biocarrier The related application of the method and using the same, the entire contents of which are hereby incorporated herein by reference in its entirety in the entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire entire all There are several factors that cause tooth decay. It is widely believed in the medical community that dental plaque (dental piaqu.e) is the main cause of bad tooth history. Plaque is a usually colorless biofilm formed by bacteria that are propagated on teeth, deposited saliva proteins, and food debris. Plaque can cause dental calculus, gingivitis, and other dental silver diseases. In addition, in plaque, Streptococcus mutans converts sugar into an organic acid, which releases hydrogen ions under the surface of the tooth enamel, causing the enamel to diffuse calcium ions and phosphate ions, causing teeth. [0004] Dental care products for eliminating bad breath and sterilization, such as mouthwashes, toothpastes, tooth powders, etc., have been used for over one hundred years. Some antibacterial 100101362 Form No. A0101 Page 3 / Total 35 pages 1002002410-0 201221153 Mouthwash 'List er er i ne®, using essential oils such as thymol, thiol Methyl salicylate 'menthol' with eucalyptol and the like as an active ingredient. In addition, 'mouthwashing usually uses alcohol (&1(:〇1)〇1) as a solvent for the active ingredient, and dissolves essential oils and/or other ingredients with a surfactant. In addition, other effective antimicrobial agents such as hexagram Cetyl pyridinum chloride (CPC), chlorhexidine gluconate, hydrogen peroxide, benzoic acid, phenolic compounds, and fluoride ( Fluoride, etc. are also often used as the main component of mouthwash. [0005] [0007] [0007] 100101362 Research has found that many of the above active ingredients may be discounted due to the presence of surfactants, and some ingredients may harm the human body. Therefore, there is a need in the art to develop a more complete and effective dental care product. .... 〇:; 匕V: [Summary of the Invention] The present invention relates to dental care with a high antibacterial effect. An embodiment of the present invention provides a dental care product comprising an orally acceptable carrier or adjuvant, and a first antibacterial having a concentration above 01 mg/ml. The antibacterial copolymer comprises a double ionic block and a tethered block having a first electrical property, wherein the anchoring segment is bonded to a tooth surface by electrostatic attraction, the diionic block orientation Externally extending to reduce the adhesion of bacteria to the surface of the tooth. Another embodiment of the invention provides a two-part dental care product, 1002002410-0, early in the morning, A0101, page 4, total 35 pages [0008] 201221153 contains the first dose And a second agent. The first agent comprises an orally acceptable first carrier or adjuvant, and a first antimicrobial copolymer having a concentration of 0.1 mg/ml or more, comprising a first diionic block and a a first tying block having a first electrical property, wherein the first tying block is bonded to a tooth surface by electrostatic attraction, the first ionic block extending outward to reduce bacterial adhesion to the a second surface comprising an orally acceptable second carrier or adjuvant, and a second antimicrobial copolymer having a concentration above 1 mg/ml, comprising a second diionic block and a第二 a second electrical block with a second electrical property, wherein The second electrical property is opposite to the first electrical electrical property, the second tying dance segment is coupled to the tooth surface by electrostatic attraction, and the second dual ionic block extends outward to reduce bacterial adhesion to the [Embodiment] [0009] The embodiments of the present invention will be described in detail below with reference to the drawings. Ο In addition to the detailed description, the present invention can be widely applied to other embodiments, any Easily substituted, modified, and equivalent changes of the embodiments are included in the scope of the present invention, and the scope of the following patents will prevail. In the description of the specification, in order to make the reader more complete, *1, the present invention may be implemented by omitting some or all of the pure details (4). In addition, steps or elements that are well known in the art are not described in detail to avoid unnecessarily limiting the present invention; the number of each of the 7C elements of the present invention may be more or less than [0010] unless otherwise limited. Oral bacteria are the main cause of bad breath and cause dental calculus and plaque in teeth and gums. Traditional dental health products use essential oils 100101362 Form No. A0101 Page 5 of 35201221153 or antibacterial agents to eliminate bacteria. Different from the prior art, the dental health care product provided by the present invention has an ultra-high anti-bacterial effect, and, surprisingly, this amazing effect can be achieved without using a conventional antibacterial agent or essential oil. . In addition, the dental care product provided by the embodiment of the present invention does not cause harm to humans. [0011] An embodiment of the present invention provides a dental care product comprising at least an orally acceptable carrier or excipient, and an antimicrobial resistance having a concentration of 0.1 mg/mL or more (bacterial resistance) Copolymer) 5 wherein an antibacterial copolymer is used as a main component. [0012] The above antibacterial copolymer comprises a zwitterionic block and an anchoring block having a first electrical property. In this embodiment, the tie block can be positively or negatively charged, i.e., the first electrical property can be positive or negative. The tie block essentially consists of a positively charged monomer or a negatively charged monomer. Wherein the positively charged monomer may be selected from one or a combination of the following groups: 100101362

表單編號A0101 第6頁/共35頁 1002002410-0 201221153Form No. A0101 Page 6 of 35 1002002410-0 201221153

ΟΟ

ο [0013] 此外,帶負電的單體可選自下列族群的其中之一或其 組合: 100101362 表單編號Α0101 第7頁/共35頁 1002002410-0 201221153Further, the negatively charged monomer may be selected from one or a combination of the following groups: 100101362 Form number Α 0101 Page 7 of 35 1002002410-0 201221153

[0014] 第一圖顯示根據本發明上述實施例之抗菌共聚物的抗 菌機制。人類牙齒表面應該是自然混合帶電的表面。根 據此特徵,本發明實施例的繫住嵌段利用靜電吸引力結 合牙齒表面,而雙離子性嵌段向外延伸,以減少細菌, 包含轉糖鏈球菌,附著於牙齒表面。值得注意的是,上 述抗菌機制僅作為理論,本發明牙齒保健產品的實施方 式也可能不限於上述理論。 [0015] 另外,上述雙離子性嵌段是由一雙離子性單體聚合而 成。上述雙離子性單體是選自下列群組的其中之一或其 組合:硫代甜菜驗(3111{〇56士3丨1!6)、叛基甜菜驗 (carboxylbetaine)、前述兩單體的衍生物、前述三者 的任意組合。在一實施例,上述雙離子性單體是取自下 列群組的其中之一或其組合: 100101362 表單編號A0101 第8頁/共35頁 1002002410-0 201221153The first figure shows the antibacterial mechanism of the antibacterial copolymer according to the above embodiment of the present invention. The surface of the human tooth should be a naturally mixed surface. According to this feature, the tying block of the embodiment of the present invention utilizes electrostatic attraction to bond the surface of the tooth, while the diionic block extends outward to reduce bacteria, including S. subtilis, and adhere to the tooth surface. It is to be noted that the above-mentioned antibacterial mechanism is only a theory, and the implementation of the dental care product of the present invention may not be limited to the above theory. Further, the above-mentioned diionic block is formed by polymerization of a double ionic monomer. The above diionic monomer is one or a combination selected from the group consisting of thio beet test (3111 {〇56士3丨1!6), carboxylbetaine, and the aforementioned two monomers. Derivatives, any combination of the foregoing. In one embodiment, the diionic monomer is one or a combination of the following groups: 100101362 Form No. A0101 Page 8 of 35 1002002410-0 201221153

100101362 表單編號A0101 第9頁/共35頁 1002002410-0 201221153 版 尸3100101362 Form No. A0101 Page 9 of 35 1002002410-0 201221153 Edition Corpse 3

SC 〇 D D D K 't t%2. K3- ,N+〆、、_▲、隣》作 Ο Η\SC 〇 D D D K 't t%2. K3- , N+〆, _▲, or neighboring 作 Η Η\

H2GH2G

ϊ r3 \\ /、(c_ o 與 100101362 表單編號A0101 第10頁/共35頁 1002002410-0 201221153ϊ r3 \\ /, (c_ o and 100101362 Form No. A0101 Page 10 of 35 1002002410-0 201221153

Ο [0016] 其中S、R2、R3、R4、R5為燒基,而η、m分別為2至5 的正整數。在本發明另一實施例’上述雙離子性嵌段可 利用一雙離子性單元聚合而成,且該雙離子性單元包含 渴*合電荷單體’其包含兩種電性相反的化合物(包含前述 任何帶正電與帶負電單體),但:聲體帶中蜣。 [0017] Ο 較佳地’前述抗牙菌共聚物丨韵重量平均分子量 (weight average moleculear weight,Μ )等於或 w 大於15 kDa’前述雙離子性嵌段的重量平均分子量等於 或大於10 kDa。本發明提供的上述牙齒保健產品可以下 列型,%存在:牙粉(dentifrice)、牙膏(toothpaste) 、漱口水(mouthwash)、牙齒預洗劑(pro-rinse)、假 牙清潔劑(denture cleaning agent)等等,其中較佳 為漱口水。另外,如有需要,上述牙齒保健產品可利用 標準已知的配方,配製成粉狀、膠狀、,泡沫、膏狀、口 100101362 表單編號A0101 第11頁/共35頁 1002002410-0 201221153 香糖、濃㈣綠’以錢料形式。如果是配製成旋 狀’則使用者在使用之前,可先將牙純⑽溶解於水 [0018] [0019] [0020] 本發明的另-實施例提供一種具有兩種配方的牙齒保 健產品,包含—第—劑與—第二劑。其中兩劑的成分均 與前述實_相同,不同處在於其中—劑的繫住後段帶 正電,而另一劑的繫住嵌段帶負電。 上述第齊】與第二劑可分別儲存於兩個容器,以被使 用依序使用。較时❹_序,或者任何順序 都可以。在本發明的兩個前述實_中,具有兩劑的牙 齒保健產品,會比以單劑形式存在的保健產品,具有更 好的抗牙菌效果。 本發明的共聚物較佳為一嵌段共聚物(bi〇ck c〇_ polymer),例如雙嵌段共聚物(dibl〇ck c〇p〇lymer, 如第一圖所示者)、三嵌段关聚物(tribl〇ck c〇p〇ly_ mer)、多丧段共聚物(multibi〇ck c〇p〇lymer)、星狀 ' ..... 喪共聚物(starblock cojiblymer),與接枝嵌段共聚 物(graft block copolymer)等等。或者,本發明的共 聚物也可以是無規則共聚物(rand〇fll c〇p〇iymer)、分 支共聚物(branched polymer) '梯度共聚物 (gradient copolymer)等等。這些其他形式的共聚物 範例,有些已揭露於前述的美國專利申請案,rSurface anti-biomolecule agent」,其說明書全文併入本文 ’視為本案說明書的一部分。只要利用如第一圖所示的 抗牙菌機制,上述各種形式的共聚物相信也能達到一樣 100101362 表單編號A0101 第12頁/共35頁 1002002410-0 201221153 [0021] Ο [0022] 的抗牙菌效果。 在本發明的眾實施例中,用於傳輸有效成分的載體基 本上是一水溶性介質,可包含水、水與界面活性劑的混 合物、水/界面活性劑/溶劑混合物,或類似混合物等等 。本發明牙齒保健產品所使用的載體可以不含酒精成分 Calcohol-free)。界面活性劑可能是用於增加一些成分 ’例如調味油(flavoring 〇ils)的溶解度。熟悉本領 域技藝人士可查明的任何食品級的界面活性劑,都可以 被應用於本發明的眾實施例中。較佳地,本發明的牙齒 保健產品使用非離子性:的.(n〇n_i〇nic)界面活性劑,其 添加量足夠使得所欲溶解的成分溶解》 本發明上述實施例的牙齒保健產品,在未使用任何精 油或抗菌劑的條件下,仍可具有高抗菌效果《儘管並非 必需’在本發明其他實施例中的牙齒保健產品,仍可能 包含精油或抗菌劑。可能被使用到的抗菌劑包含三氣沙 (triclosan)、十六炫^基氣化础咬(cetyl pyridium chloride)、溴化十二烷基-二甲基-2-苯氧基-乙基胺 (domiphen bromide,度米芬)、四級銨鹽 (quaternary ammonium salts)、鋅化合物(zinc compounds)、血根驗水溶性焦墙酸(sanguinarine soluble pyrophosphates)、氟化物(fluorides)、 阿來西定(alexidine)、乙二胺四乙酸(EDTA)。 另外,如果有需要,本發明實施例的牙齒保健產品, 可包含其他在習知口腔保健產品所經常使用的配方添加 劑’.例如調味劑(flavouring agents)、甜味劑 100101362 表單編號A0101 第13頁/共35頁 1002002410-0 [0023] 201221153 (sweetening agents)、增色劑(colouring agents) 、漢揭劑(thickening agents)、濕潤劑 (humectants)、軟化劑(softeners)、防腐劑 (preservatives)等等。這些附加成分的要求是必須與 本發明實施例的有效成分相容,且添加的前提是為了達 到特定的目的或功效。本領域熟悉技藝人士可根據所要 達到的結果,選擇使用這些成分並配製適當比例。 [0024] 範例 [0025]S [0016] wherein S, R2, R3, R4, and R5 are alkyl groups, and η and m are each a positive integer of 2 to 5. In another embodiment of the present invention, the above diionic block may be polymerized using a double ionic unit, and the diionic unit comprises a thirsty charge monomer comprising two compounds of opposite electrical properties (including Any of the foregoing positively charged and negatively charged monomers), but: the sound is in the middle of the belt. [0017] Preferably, the aforementioned anti-bacterial copolymer has a weight average molecular weight (Μ) equal to or w greater than 15 kDa. The weight average molecular weight of the above-mentioned diionic block is equal to or greater than 10 kDa. The above dental care product provided by the present invention may be of the following types, such as dentifrice, toothpaste, mouthwash, pro-rinse, denture cleaning agent, etc. Etc. Among them, mouthwash is preferred. In addition, if necessary, the above dental care products can be formulated into powders, gels, foams, pastes, and mouths using standard known formulations. Form No. A0101 Page 11 of 35 pages 1002002410-0 201221153 Sugar, rich (four) green 'in the form of money. If it is formulated into a spin shape, the user may first dissolve the tooth pure (10) in water before use [0018] [0020] Another embodiment of the present invention provides a dental care product having two formulations. Containing - the first agent and the second agent. The ingredients of both of them are the same as the above, except that the agent is positively charged in the latter part and the blocking block of the other agent is negatively charged. The above-mentioned first and second agents can be separately stored in two containers to be used in sequence. Time ❹ _ order, or any order can be. In the two previous embodiments of the present invention, a dental care product having two doses has a better antibacterial effect than a health care product in a single dose. The copolymer of the present invention is preferably a block copolymer (bi〇ck c〇_polymer), such as a diblock copolymer (dibl〇ck c〇p〇lymer, as shown in the first figure), three inlays Segmental polycondensate (tribl〇ck c〇p〇ly_ mer), multi-segmented copolymer (multibi〇ck c〇p〇lymer), star-shaped ... (.starblock cojiblymer), and grafting Graft block copolymer and the like. Alternatively, the copolymer of the present invention may be a random copolymer (rand〇fll c〇p〇iymer), a branched polymer 'gradient copolymer, and the like. Some of these other forms of copolymers are disclosed in the aforementioned U.S. Patent Application, rSurface anti-biomolecule agent, the entire disclosure of which is incorporated herein by reference. As long as the anti-bacterial mechanism as shown in the first figure is utilized, the above various forms of copolymers are believed to achieve the same 100101362 Form No. A0101 Page 12/35 pages 1002002410-0 201221153 [0021] 抗 [0022] Bacterial effect. In the embodiments of the present invention, the carrier for transporting the active ingredient is substantially an aqueous medium, and may comprise water, a mixture of water and a surfactant, a water/surfactant/solvent mixture, or the like, and the like. . The carrier used in the dental care product of the present invention may be free of alcoholic ingredients Calcohol-free). Surfactants may be used to increase the solubility of some ingredients, such as flavoring 〇ils. Any food grade surfactant that can be ascertained by those skilled in the art can be utilized in the various embodiments of the present invention. Preferably, the dental care product of the present invention uses a nonionic: (n〇n_i〇nic) surfactant which is added in an amount sufficient to dissolve the component to be dissolved. The dental health care product of the above embodiment of the present invention, It is possible to have a high antibacterial effect without using any essential oil or antibacterial agent. Although it is not necessary, the dental care product in other embodiments of the present invention may contain essential oils or antibacterial agents. Antibacterial agents that may be used include triclosan, cetyl pyridium chloride, dodecyl-dimethyl-2-phenoxy-ethylamine bromide (domiphen bromide, quaternary ammonium salts, zinc compounds, sanguinarine soluble pyrophosphates, fluorides, alexidine (alexidine), ethylenediaminetetraacetic acid (EDTA). In addition, the dental care product of the embodiment of the present invention may include other formula additives frequently used in conventional oral care products, such as flavouring agents, sweeteners 100101362, Form No. A0101, page 13 if necessary. / Total 35 pages 1002002410-0 [0023] 201221153 (sweetening agents), colouring agents, thickening agents, humectants, softeners, preservatives, etc. . The requirements for these additional ingredients must be compatible with the active ingredients of the embodiments of the invention, and the premise of addition is to achieve a particular purpose or efficacy. Those skilled in the art will be able to opt in and formulate appropriate ratios based on the desired results. Example [0025]

表一列出由本發明實施例所製備9種抗牙菌共聚物的特 性。這9種共聚物可分成三大類:(1)具有一疏水嵌段(作 為繫住嵌段)以及一雙離子性嵌段的嵌段共聚物,例如聚 氧丙烯[poly(propylene oxide),PP0]與聚硫代甜菜 驗丙稀酸醋[poly(sulfobetaine methacrylate, PSBMA)]的嵌段共聚物(PPO-b-PSBMA);具有一帶正電 繫住嵌段以及一雙離子性嵌段的嵌槔共聚物,例如聚甲 基丙烯醯氧乙基三曱基氣化銨Table 1 lists the characteristics of the nine antifungal copolymers prepared by the examples of the present invention. These nine copolymers can be divided into three major categories: (1) block copolymers having a hydrophobic block (as a tie block) and a double ionic block, such as poly(propylene oxide), PP0 a block copolymer (PPO-b-PSBMA) with poly(sulfobetaine methacrylate (PSBMA)); with a positively charged block and a double ionic block Ruthenium copolymer, such as polymethacryloyloxyethyltrimethylammonium vapor

(poly(l1-mercapto-N,N,N trimethyl ammonium(poly(l1-mercapto-N, N, N trimethyl ammonium)

chloride,PTMA)與聚硫代甜菜驗丙烯酸酯(PSBMA)的 散段共聚物(PTMA-b-PSBMA) ; (3)具有一帶負電繫住 嵌段以及一雙離子性嵌段的嵌段共聚物,例如聚二茂鐵 績酸[poly(11-mercaptoundecy 1 sulfonic acid), PSA]與聚硫代甜菜鹼丙烯酸酯(PSBMA)的嵌段共聚物 (PSA-b-PSBMA)。上述九種共聚物可以使用原子轉移自 由基聚合法(atom transfer radical polymerization,ATRP),製備成各種單體重複數量的樣本,但不 100101362 表單編號A0101 第14頁/共35頁 1002002410-0 201221153 限於此。 表一 樣品ID 共聚物性質 PSBMA含量 單體數 量 Zeta 電位 水力 直徑 Mw (g/mol) Mw of poly Mw of PSBMA (wt%) (mol%) m n 1 mg/ml 1 mg/ml PP〇20-b-PSBMA10 3952 1.267 1057 2S95 73.3 33.3 20 10 •0.2 〜10 PPOo-b-PSBMAzo 6038 1.217 1057 4981 82.5 47.4 20 18 -0.5 〜10 PP020-b-PSBMA4〇 12775 1.236 1057 11718 91.7 67.7 20 42 +0.7 〜11 PTMA20-b-PSBMA10 7765 1.214 4596 3169 40.8 33.3 22 11 +1.4 ~10 PTMA^b-PSBMAa, 10176 1.435 4596 5592 55.0 47.6 22 20 +3.2 〜10 PTMA2〇-b-PSBMA4〇 16158 1.312 4596 11562 71.6 65.1 22 41 +4.3 ~13 PSA2〇-b-PSBMA|〇 7750 1.207 5060 2690 34.7 32.3 21 10 -0.9 〜10 PSA2〇-b-PSBMA2〇 10620 1346 5060 5660 53.3 48.8 21 20 -2.8 〜11 PSA2〇-b-PSBMA4〇 15202 1.287 5060 10142 66.7 63.2 21 36 -3.7 ~12 Ο [0026] 第二圖顯示根據本發明實施例所製備9種共聚物的實驗 室試驗計劃。首先分別準備一些試驗溶液,每種試驗溶 液各包含一種表一所列的共聚物。接'著分.別將經碟灰石 (hydroxyl apatite)圓盤或人類真牙浸沒於—試驗溶液 一段時間後,檢視各種試驗溶液的抗細菌效果。所製備 的試驗溶液可分為四種類型:第一型、第1^型、第三型 、第四型。第一型耳第三型溶液為前述的單劑型溶液, 分別以PPO-b-PSBMA(l)、PSA-b-PSBMA (2) 、ρτΜΑ_ b-PSBMA(3)作為有效成分。第四型溶液為前述的雙劑型Chloride, PTMA) and polystyrene beet acrylate (PSBMA) as a bulk copolymer (PTMA-b-PSBMA); (3) block copolymer with a negatively charged block and a double ionic block For example, a block copolymer (PSA-b-PSBMA) of poly(11-mercaptoundecy 1 sulfonic acid), PSA] and polythiobetaine acrylate (PSBMA). The above nine copolymers can be prepared by atom transfer radical polymerization (ATRP) to prepare a sample of various monomer repeats, but not 100101362 Form No. A0101 Page 14 of 35 1002002410-0 201221153 Limited this. Table 1 Sample ID Copolymer Properties PSBMA Content Monomer Quantity Zeta Potential Hydraulic Diameter Mw (g/mol) Mw of poly Mw of PSBMA (wt%) (mol%) mn 1 mg/ml 1 mg/ml PP〇20-b -PSBMA10 3952 1.267 1057 2S95 73.3 33.3 20 10 •0.2 ~10 PPOo-b-PSBMAzo 6038 1.217 1057 4981 82.5 47.4 20 18 -0.5 ~10 PP020-b-PSBMA4〇12775 1.236 1057 11718 91.7 67.7 20 42 +0.7 〜11 PTMA20 -b-PSBMA10 7765 1.214 4596 3169 40.8 33.3 22 11 +1.4 ~10 PTMA^b-PSBMAa, 10176 1.435 4596 5592 55.0 47.6 22 20 +3.2 ~10 PTMA2〇-b-PSBMA4〇16158 1.312 4596 11562 71.6 65.1 22 41 + 4.3 ~13 PSA2〇-b-PSBMA|〇7750 1.207 5060 2690 34.7 32.3 21 10 -0.9 ~10 PSA2〇-b-PSBMA2〇10620 1346 5060 5660 53.3 48.8 21 20 -2.8 ~11 PSA2〇-b-PSBMA4〇15202 1.287 5060 10142 66.7 63.2 21 36 -3.7 ~12 第二 [0026] The second figure shows a laboratory test plan for the preparation of nine copolymers in accordance with an embodiment of the present invention. First, test solutions were prepared separately, each of which contained a copolymer listed in Table 1. After the lapse of the test, the antibacterial effect of the various test solutions is checked after a period of time. The test solutions prepared can be classified into four types: first type, first type, third type, and fourth type. The first type ear type third solution is the above single-form type solution, and PPO-b-PSBMA (1), PSA-b-PSBMA (2), and ρτΜΑ_ b-PSBMA (3) are respectively used as active ingredients. The fourth type of solution is the aforementioned two dosage form

溶液,兩劑分別以PTMA-b-PSBMA(3)與 PSA-b-PSBMA (2)作為有效成分;在試驗時’取一經碟灰石圓盤或人類 真牙’以預定的順序’先浸沒於其中一劑一段時間後, 再浸沒於另一劑一段時間。於圖示中’亦顯示所製備的 共聚物會以自組裝(self-assembled)的方式,包含疏 水互相作用力與靜電吸引力,附著在羥磷灰石圓盤或人 類真牙的表面上。由於第二、第三型皆為單劑型溶液, 100101362 1002002410-0 表單編號A0101 第15頁/共35頁 201221153 在共聚物的繫住嵌段之間可能會存在有靜電互斥力。相 較之下’當輕鱗灰石圓盤或人類真牙的表面分別塗佈上 第四型溶液的兩劑後,在共聚物的繫住嵌段之間應該存 在有靜電吸引力。 [0027] [0028] 第三圖顯示本發明實施例所製備4型溶液的附著試驗。 對於第一、第二、第三型溶液的製備,是將每種前述的 共聚物分別以不同分子量與不同濃度,自〇. 〇1 „^/1„1至 1 mg/ml,溶解於磷酸鹽缓衝液(phosphate buffer saline ’ PBS)中。試驗時取輕磷灰石圓盤置於試驗溶液 中’觀察每種共聚物的附著能力。較.高的共聚物附著量 表示’該共聚物溶液具有較好的與經碌灰石表面附著能 力。對於第四型溶液的製備,是將PSA^-b-PSBMA盥 PTMA20—b-PSBMA4()以1 mg/ml的濃度分別溶解在兩組破 酸鹽緩衝液中,作為兩劑型牙齒保健產品的兩劑。為觀 察兩劑使用順序的影響,樣品(a)是將一羥磷灰石圓盤,Solution, two doses of PTMA-b-PSBMA (3) and PSA-b-PSBMA (2) as active ingredients; in the test 'take a disc or disc of human real teeth' in a predetermined order first immersed After one of the doses, it is immersed in another dose for a while. It is also shown in the figure that the prepared copolymer will adhere to the surface of a hydroxyapatite disc or human real tooth in a self-assembled manner, including hydrophobic interaction and electrostatic attraction. Since both the second and third types are single-dose solutions, 100101362 1002002410-0 Form No. A0101 Page 15 of 35 201221153 There may be electrostatic mutual repulsion between the anchoring blocks of the copolymer. In contrast, when two surfaces of the fourth type solution are coated on the surface of a light limet disc or a human real tooth, there should be an electrostatic attraction between the anchoring blocks of the copolymer. [0028] The third figure shows the adhesion test of the type 4 solution prepared in the examples of the present invention. For the preparation of the first, second, and third types of solutions, each of the foregoing copolymers is dissolved in phosphoric acid at different molecular weights and concentrations, from 〇1 „^/1 „1 to 1 mg/ml. In salt buffer saline 'PBS. A light apatite disk was placed in the test solution during the test to observe the adhesion of each copolymer. The higher adhesion of the copolymer indicates that the copolymer solution has a better adhesion to the surface of the limestone. For the preparation of the fourth type of solution, PSA^-b-PSBMA盥PTMA20-b-PSBMA4() was dissolved in the two groups of the buffer solution at a concentration of 1 mg/ml as a two-part dental care product. Two doses. To observe the effect of the two-use sequence, sample (a) is a monohydroxyapatite disc,

先塗佈PSA -b-PSBMA 後’再塗佈PTMA -b-PSBMA 乙 u 4υ L 〇 4〇 ;樣品(b)是將另一羥磷灰石圓Μ,先塗佈ΡΤΜΑ - 20 b-PSBMA 後,再塗佈PSA9n-b-PSBMA 。 40 2 U 40 如第三圖所示’對於羥璘灰石表面,第一型溶液顯示 不佳的附著能力;第二型與第三型溶液顯示,除了濃度 為0 · 01 mg/m 1外的樣品,皆具有良好的附著能力;第四 型溶液顯示,無論是先塗佈哪一劑,兩樣品都具有極佳 的附著能力。 因為蛋白質沉積在牙齒表面會幫助口腔細菌導致各種 牙齒疾病,因此一個好的牙齒保健產品應該提供良好的 100101362 表單編號A0101 第16頁/共35頁 1002 [0029] 201221153 抗蛋白質吸附能力。第四圖顯示根據本發明實施例所製 備四型溶液,以及比較樣品,包含聚笨乙烯 (polystyrene,PS)、羥磷灰石(HA)、李施德林漱口水 、PSBM A膠等的單蛋白質吸附試驗,其中四型溶液的製備 方式如前所述,但共聚物的濃度皆固定於j mg/ml。 [0030] Ο 試驗時,將每個試驗溶液浸入一羥磷灰石圓盤,使溶 液中的有效成分塗佈在圓盤的表面上。接著將羥磷灰石 圓盤與人類血漿纖維蛋白溶液接觸,以評估試驗溶液的 抗蛋白吸附能力。所有試驗溶液的蛋白質吸附數據,以 未經抗菌處理的HA表面的蛋白質吸附數據,進行標準化 (normalized)。實驗結果顯示,經第一型溶液處理過的 HA表面,與未經抗菌處理的BA表面,具有相似的蛋白質 吸附量。經第二型溶液或第三型溶液處理過的HA表面, 具有可接受的抗蛋白質吸附能力。經第四型溶液處理過 的HA表面’比經過李施德林漱口水處理過的HA表面,具 有更優異的抗蛋白質吸附能力。 Q [0031] 第五A至第五E圖以及第六圊顯示本發明實施例所製備4 塑溶液,以及比較樣品’包含聚苯乙烯(PS)、羥磷灰石 (HA)、李施德林漱口水、PSBMA膠等的細菌覆蓋試驗, 其中第五A圖至第五E圖為進行細菌覆蓋測試後的照片, 第六圖則是第五A圖至第五E圖的數據資料。將許多經鱗 灰石圓盤個別經過第一型至第四型溶液、李施德林漱口 水、PSBMA膠,以如同前述的方法處理後,使其與人類啥 液接觸72小時,以表面上的細菌覆蓋率評估其抗菌能力 。人類唾液具有轉糖鏈球菌,會在羥磷灰石圓盤表面上 100101362 表單編號A0101 第17頁/共35頁 1002002410-0 201221153 形成生物薄膜,而此生物薄膜的覆蓋比率,可用來評估 試驗溶液中之有效成分的抗菌能力。在與唾液接觸3小時 、24小時、72小時後,分別記錄羥磷灰石圓盤表面的圖 像與數據資料。所有的實驗步驟,在等同人類生理的條 件下進行。 [0032] 另外,以未經任何抗菌處理的HA表面的生物薄膜覆蓋 率,作為比較的參考表面,其中呈現(綠色)斑點狀的即 為生物薄膜所在處。與未經抗菌處理的HA表面相比較, 所有經第一型溶液處理後的HA表面,無論溶液中所含共 聚物的分子量為何,只呈現些微的抗菌能力。經第二型 溶液處理後的HA表面,除了樣品編號PSA2()-b-PSBMA1() 外,都呈現不錯的抗菌能力,此表示這一型牙齒保健溶 液的有效成分,其雙離子性嵌段的分子量,應該接近或 大於繫住嵌段的分子量。經第三型溶液處理後的HA表面 ,顯示第三型溶液具有略優於第二型溶液的抗菌能力; 在試驗時間3小時與24小時之後,三個第三型溶液處理後 的HA表面皆顯示出良好的抗菌能力。從實驗結果亦觀察 到具有較高分子量的PSBMA樣品溶液,會具有較好的抗菌 能力。經第四型溶液處理後的HA表面,顯示第四型溶液 具有極佳的抗菌能力,且樣品(a)優於樣品(b)。對於樣 品(a),試驗時間3小時後未出現生物薄膜,試驗時間72 小時後的細菌覆蓋率小於3%。對於樣品(b),試驗時間48 小時後仍未出現生物薄膜,試驗時間72小時後才出現微 量的細菌覆蓋。而經比較樣品李施德林漱口水處理後的 HA表面,試驗時間3小後出現少量的細菌覆蓋,試驗時間 100101362 表單編號A0101 第18頁/共35頁 1002002410-0 201221153 [0033] Ο [0034] Ο [0035] [0036] 24小時後的細菌覆蓋率增加至約1 0%,試驗時間48小時後 的細菌覆蓋率增加至約60〇/〇。 第七圖與第八圖顯示類似於第五Α至第五Ε圖以及第六 圖的細菌覆蓋測試,只是受測試對象,從模擬牙齒的羥 碟灰石(ΗΑ)圓盤’更換為人類真牙。第七圖為在人類牙 齒上塗佈本發明實施例所製備的牙齒保健溶液後,進行 、、田菌覆蓋測试後的照片。第八圖顯示第七圖的數據資料 由於人類真牙難以取得,對於第二型溶液與第三型溶 液,僅各選取一種共聚物樣品做測試,且取消第一型溶 液的測試。同樣,未經任何有效成分處理過的人類真牙 表面,被當作參考表面。 ’…' 如第七圖與第八圖所示,包含pSA _pSBM p c υ 4 0 MA2(Tb_PSBMA4〇的試驗溶液,顯示具有可比得上李施 德林漱口水的抗菌能力。而經第四型溶液,不管是樣品 (a)或樣品(b),均顯示具有優於李施德林漱口水的抗菌 能力。 以上實驗數據顯示本發明實施例所提供的牙齒保健溶 液,具有可相當,甚至優於市售產品李施德林漱口水的 抗菌能力。 以上所述僅為本發明之較佳實施例而已,並非用以限 定本發明之申請專利範圍;凡其他未脫離發明所揭示之 精神下所完成之等效改變或修飾,均應包含在下述之申 請專利範圍内》 【圖式簡單說明】 100101362 表單編號A0101 第19頁/共35頁 1002002410- 201221153 [0037] 第一圖顯示根據本發明一實施例之抗菌共聚物的抗菌機 制, 第二圖顯示根據本發明實施例所製備九種共聚物的實驗 室試驗計劃, 第三圖顯示本發明實施例所製備四型溶液的附著試驗; 第四圖顯示根據本發明實施例所製備四型溶液的單蛋白 質吸附試驗; 第五A圖至第五E圖為在經填灰石(hydroxyl apatite)圓 盤上塗佈本發明實施例所製備的牙齒保健溶液後,進行 細菌覆蓋測試後的照片; 第六圖顯示第五A圖至第五E圖的數據資料; 第七圖為在人類牙齒上塗佈本發明實施例所製備的牙齒 保健溶液後,進行細菌覆蓋測試後的照片; 第八圖顯示第七圖的數據資料。 【主要元件符號說明】 [0038] 無。 100101362 表單編號A0101 第20頁/共35頁 1002002410-0After coating PSA-b-PSBMA, 'recoat PTMA-b-PSBMA 乙 u 4υ L 〇4〇; sample (b) is another hydroxyapatite round Μ, first coated ΡΤΜΑ - 20 b-PSBMA After that, PSA9n-b-PSBMA was coated. 40 2 U 40 As shown in the third figure, 'For the hydroxyapatite surface, the first type of solution shows poor adhesion; the second and third types of solutions show that except for the concentration of 0 · 01 mg/m 1 The samples all have good adhesion; the fourth type of solution shows that both samples have excellent adhesion regardless of which one is applied first. Because protein deposition on the tooth surface can help oral bacteria cause various dental diseases, a good dental care product should provide good 100101362 Form No. A0101 Page 16 of 35 1002 [0029] 201221153 Anti-protein adsorption capacity. The fourth figure shows a four-form solution prepared according to an embodiment of the present invention, and a comparative sample comprising single protein adsorption of polystyrene (PS), hydroxyapatite (HA), Li Shi Delin mouthwash, PSBM A gel, and the like. The test, in which the four types of solution were prepared as described above, but the concentration of the copolymer was fixed at j mg/ml. [0030] In the test, each test solution was immersed in a hydroxyapatite disk, and the active ingredient in the solution was coated on the surface of the disk. The hydroxyapatite disc is then contacted with a human plasma fibrin solution to assess the anti-protein adsorption capacity of the test solution. The protein adsorption data of all test solutions were normalized to the protein adsorption data of the HA surface without antibacterial treatment. The experimental results show that the surface of the HA treated with the first type of solution has a similar protein adsorption amount to the surface of the BA which has not been treated with antibacterial treatment. The HA surface treated with the second type solution or the third type solution has an acceptable anti-protein adsorption ability. The surface of the HA treated with the fourth type solution has superior anti-protein adsorption capacity than the surface of the HA treated with the Li Shi Delin mouthwash. Q [0031] The fifth to fifth E and sixth arrows show the 4 plastic solution prepared in the examples of the present invention, and the comparative sample 'comprises polystyrene (PS), hydroxyapatite (HA), and Li Shi Delin Bacterial coverage test of saliva, PSBMA glue, etc., wherein the fifth A to fifth E pictures are photographs after the bacterial coverage test, and the sixth figure is the data data of the fifth A to fifth E pictures. A plurality of petrophyte discs were individually passed through a first to fourth type solution, a Li Shi Delin mouthwash, and a PSBMA gel, and treated with the human sputum for 72 hours as the surface bacteria were treated as described above. Coverage rate is evaluated for its antibacterial ability. Human saliva has S. mutans, which will form a biofilm on the surface of the hydroxyapatite disc 100101362 Form No. A0101 Page 17 of 352002410-0 201221153, and the coverage ratio of this biofilm can be used to evaluate the test solution. The antibacterial ability of the active ingredients in the medium. Images and data on the surface of the hydroxyapatite disc were recorded after 3 hours, 24 hours, and 72 hours of contact with saliva. All experimental procedures were performed under conditions equivalent to human physiology. In addition, the biofilm coverage of the HA surface without any antibacterial treatment was used as a comparative reference surface in which the (green) spotted shape was located where the biofilm was located. Compared to the surface of the HA which has not been treated with antibacterial treatment, all of the surface of the HA treated with the first type of solution exhibits only a slight antibacterial ability regardless of the molecular weight of the copolymer contained in the solution. The HA surface treated with the second type solution showed good antibacterial ability except for the sample number PSA2()-b-PSBMA1(), which indicates the active ingredient of this type of dental care solution, and its diionic block. The molecular weight should be close to or greater than the molecular weight of the tied block. The HA surface treated by the third type solution showed that the third type solution had slightly better antibacterial ability than the second type solution; after 3 hours and 24 hours of the test time, the HA surfaces after the treatment of the three third type solutions were all Shows good antibacterial ability. It has also been observed from the experimental results that the PSBMA sample solution having a higher molecular weight has better antibacterial ability. The surface of the HA treated with the solution of the fourth type showed that the fourth type solution had excellent antibacterial ability, and the sample (a) was superior to the sample (b). For the sample (a), no biofilm appeared after 3 hours of the test time, and the bacterial coverage after 72 hours of the test time was less than 3%. For sample (b), biofilm did not appear after 48 hours of test time, and microbial coverage did not occur until 72 hours after the test time. On the HA surface after the treatment of the sample sample Li Shi Delin mouthwash, a small amount of bacterial coverage appeared after 3 hours of test time, test time 100101362 Form No. A0101 Page 18 / Total 35 Page 1002002410-0 201221153 [0033] Ο [0034] Ο [0036] The bacterial coverage after 24 hours increased to about 10%, and the bacterial coverage after 48 hours of the test time increased to about 60 〇/〇. Figures 7 and 8 show bacterial coverage tests similar to the fifth to fifth and sixth, except that the subject is replaced by a hydroxyapatite (ΗΑ) disc that simulates the teeth. tooth. The seventh figure is a photograph of the dental care solution prepared in the examples of the present invention after applying the dental care solution prepared in the examples of the present invention. The eighth figure shows the data of the seventh figure. Since human real teeth are difficult to obtain, for the second type solution and the third type solution, only one copolymer sample is selected for testing, and the first type solution is removed. Similarly, the surface of a human tooth that has not been treated with any active ingredient is used as a reference surface. '...' As shown in the seventh and eighth figures, the test solution containing pSA _pSBM pc υ 4 0 MA2 (Tb_PSBMA4〇 showed an antibacterial ability comparable to that of Li Shi Delin mouthwash. Whether it is sample (a) or sample (b), both show an antibacterial ability superior to Li Shi Delin mouthwash. The above experimental data shows that the dental care solution provided by the embodiment of the present invention has comparable or even superior quality to the commercially available product Lee. The antibacterial ability of the Sterling Mouthwash is only the preferred embodiment of the present invention, and is not intended to limit the scope of the present invention; any equivalent changes or modifications made without departing from the spirit of the invention. All of them should be included in the scope of the following patent application. [Simple Description of the Drawings] 100101362 Form No. A0101 Page 19/35 pages 1002002410-201221153 [0037] The first figure shows an antibacterial copolymer according to an embodiment of the present invention. Antibacterial mechanism, the second figure shows a laboratory test plan for preparing nine copolymers according to an embodiment of the present invention, and the third figure shows the preparation of the examples of the present invention. The adhesion test of the type solution; the fourth figure shows the single protein adsorption test of the four type solution prepared according to the embodiment of the present invention; the fifth to fifth E pictures are coated on the port of the hydroxyl apatite After the dental care solution prepared in the embodiment of the present invention, the photograph after the bacterial coverage test is performed; the sixth figure shows the data of the fifth A to the fifth E; and the seventh figure is the application of the present invention on the human tooth. After the dental care solution prepared in the example, the photograph after the bacterial coverage test is performed; the eighth figure shows the data of the seventh figure. [Main component symbol description] [0038] None. 100101362 Form No. A0101 Page 20 of 35 1002002410-0

Claims (1)

201221153 七、申請專利範圍: 1 . 一種牙齒保健產品,包含: 一口腔可接受的載體或輔藥;以及 一濃度在0. 1 mg/ml以上的一第一抗菌共聚物,包含一雙 離子性嵌段與一具有第一電性的繫住嵌段,其中該繫住嵌 段藉由靜電吸引力與一牙齒表面結合,該雙離子性嵌段向 外延伸,以減少細菌附著於該牙齒表面。 2 .如申請專利範圍第1項的牙齒保健產品,其中該第一電性 為正電。 〇 3 .如申請專利範圍第1項的牙齒保健產品,其中該第一電性 為負電。 4 .如申請專利範圍第1項的牙齒保健產品,其中該雙離子性 嵌段係利用一雙離子性單體聚合而成,該雙離子性單體係 選自下列群組的其中之一:硫代甜菜驗(sufobetaine) 、缓基甜菜驗(carboxylbetaine)、前述兩單體的衍生 物、前述三者的任意組合。 5 .如申請專利範圍第1項的牙齒保健產品,其中該雙離子性 0 嵌段係利用一雙離子性單元聚合而成,且該雙離子性單元 包含混合電荷單體,其包含兩種電性相反的化合物,但整 體帶中性。 6 .如申請專利範圍第1項的牙齒保健產品,其中該第一抗菌 共聚物的重量平均分子量等於或大於15 kDa。 7.如申請專利範圍第1項的牙齒保健產品,其中該雙離子性 嵌段的重量平均分子量等於或大於10 kDa。 8 .如申請專利範圍第1項的牙齒保健產品,其中該牙齒保健 100101362 表單編號A0101 第21頁/共35頁 1002002410-0 201221153 產品的型態包含牙粉、牙膏、漱口水、牙齒預洗劑、假牙 清潔劑。 9 . 一種兩劑型的牙齒保健產品,包含: 一第一劑,包含: 一口腔可接受的第一載體或 輔藥;以及 一濃度在0.1 mg/ml以上的一第一抗菌共聚物,包—第 一雙離子性嵌段與一具有第一電性的第一繫住嵌段,其中 該第一繫住嵌段藉由靜電吸引力與一牙齒表面結合,該第 一雙離子性嵌段向外延伸,以減少細菌附著於該牙齒表面 » 一第二劑,包含: 一口腔可接受的第二載體或 輔藥;以及 一濃度在0. 1 mg/ml以上的一第二抗菌共聚物,包含一第 二雙離子性嵌段與一具有第二電性的第二繫住嵌段,其中 該第二電性與該第一電性的電性相反,該第二繫住嵌段藉 由靜電吸引力與該牙齒表面結合,該第二雙離子性嵌段向 外延伸,以減少細菌附著於該牙齒表面。 10 .如申請專利範圍第9項的牙齒保健產品,其中該第一電性 為正電,該第二電性為負電。 11 .如申請專利範圍第9項的牙齒保健產品,其中該第一電性 為負電,該第二電性為正電。 12 .如申請專利範圍第9項的牙齒保健產品,其中該第一雙離 子性嵌段與該第二雙離子性嵌段係利用一雙離子性單體聚 合而成,該雙離子性單體係選自下列群組的其中之一:硫 100101362 表單編號A0101 第22頁/共35頁 1002002410-0 201221153 代甜菜驗(sufobetaine)、羧基甜菜驗 (carboxylbetaine)、前述兩單體的衍生物、前述三者 的任意組合。 13 .如申請專利範圍第9項的牙齒保健產品,其中該第一雙離 子性嵌段與該第二雙離子性嵌段係利用一雙離子性單元聚 合而成,且該雙離子性單元包含混合電荷單體,其包含兩 種電性相反的化合物,但整體帶中性。 14 .如申請專利範圍第9項的牙齒保健產品,其中該第一抗菌 共聚物與該第二抗菌共聚物的重量平均分子量等於或大於 Ο 15 kDa。 15 .如申請專利範圍第9項的牙齒保健產品,其中該第一雙離 子性嵌段與該第二雙離子性嵌段的重量平均分子量等於或 大於10 kDa。 16 .如申請專利範圍第9項的牙齒保健產品,其中該牙齒保健 產品的型態包含牙粉、牙膏、漱口水、牙齒預洗劑、假牙 清潔劑。 1002002410-0 100101362 表單編號A0101 第23頁/共35頁201221153 VII. Patent application scope: 1. A dental health care product comprising: an orally acceptable carrier or adjuvant; and a first antimicrobial copolymer having a concentration above 0.1 mg/ml, comprising a double ionicity a block and a tie block having a first electrical property, wherein the tie block is bonded to a tooth surface by electrostatic attraction, the double ion block extending outward to reduce bacterial adhesion to the tooth surface . 2. The dental health care product of claim 1, wherein the first electrical property is positive. 〇 3. The dental health care product of claim 1, wherein the first electrical property is negative. 4. The dental health care product of claim 1, wherein the diionic block is polymerized using a double ionic monomer selected from one of the group consisting of: Sulfobetaine, carboxylbetaine, derivatives of the above two monomers, any combination of the foregoing. 5. The dental health care product of claim 1, wherein the diionic 0 block is polymerized using a double ionic unit, and the dual ionic unit comprises a mixed charge monomer comprising two types of electricity The opposite compound, but overall neutral. 6. The dental health care product of claim 1, wherein the first antimicrobial copolymer has a weight average molecular weight of 15 kDa or more. 7. The dental health care product of claim 1, wherein the diionic block has a weight average molecular weight of 10 kDa or more. 8. A dental care product according to claim 1 of the patent scope, wherein the dental care 100101362 Form No. A0101 Page 21 / Total 35 pages 1002002410-0 201221153 The type of the product comprises tooth powder, toothpaste, mouthwash, tooth pre-washing agent, Denture cleaner. 9. A two-part dental care product comprising: a first agent comprising: an orally acceptable first carrier or adjuvant; and a first antimicrobial copolymer having a concentration above 0.1 mg/ml, comprising - a first dual ionic block and a first tying block having a first electrical property, wherein the first tying block is bonded to a tooth surface by electrostatic attraction, the first dual ionic block Externally extending to reduce the adhesion of bacteria to the surface of the tooth» a second agent comprising: an orally acceptable second carrier or adjuvant; and a second antimicrobial copolymer having a concentration of greater than 0.1 mg/ml, The second ionic block and a second tying block having a second electrical property, wherein the second electrical property is opposite to the electrical property of the first electrical property, and the second tying block is An electrostatic attraction is combined with the tooth surface, and the second diionic block extends outward to reduce bacterial attachment to the tooth surface. 10. The dental health care product of claim 9, wherein the first electrical property is positive power and the second electrical property is negative electrical power. 11. The dental health care product of claim 9, wherein the first electrical property is a negative electrical power and the second electrical electrical property is a positive electrical energy. 12. The dental health care product of claim 9, wherein the first diionic block and the second diionic block are polymerized using a double ionic monomer, the diionic monomer Is selected from one of the following groups: sulfur 100101362 Form No. A0101 Page 22 / Total 35 pages 1002002410-0 201221153 Sub-beet test (sufobetaine), carboxyl beet test (carboxylbetaine), derivatives of the aforementioned two monomers, the foregoing Any combination of the three. 13. The dental health care product of claim 9, wherein the first diionic block and the second diionic block are polymerized using a double ionic unit, and the diionic unit comprises A mixed charge monomer that contains two compounds of opposite electrical properties, but is generally neutral. 14. The dental health care product of claim 9, wherein the first antimicrobial copolymer and the second antimicrobial copolymer have a weight average molecular weight of equal to or greater than k 15 kDa. The dental health care product of claim 9, wherein the first diionic block and the second diionic block have a weight average molecular weight of equal to or greater than 10 kDa. 16. The dental health care product of claim 9, wherein the dental care product comprises a dentifrice, a toothpaste, a mouthwash, a tooth pre-wash, and a denture cleaner. 1002002410-0 100101362 Form No. A0101 Page 23 of 35
TW100101362A 2010-11-23 2011-01-14 Dental care product TWI428150B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/953,036 US8980232B2 (en) 2010-11-23 2010-11-23 Dental care product

Publications (2)

Publication Number Publication Date
TW201221153A true TW201221153A (en) 2012-06-01
TWI428150B TWI428150B (en) 2014-03-01

Family

ID=46064549

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100101362A TWI428150B (en) 2010-11-23 2011-01-14 Dental care product

Country Status (2)

Country Link
US (2) US8980232B2 (en)
TW (1) TWI428150B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933173B2 (en) * 2010-11-23 2015-01-13 Chung Yuan Christian University Surface anti-biomolecule agent
WO2014074854A1 (en) 2012-11-09 2014-05-15 Wang Tongxin Block copolymers for tooth enamel protection
GB201505465D0 (en) * 2015-03-30 2015-05-13 Revolymer U K Ltd Uses of polymers
GB2562437B (en) 2016-01-28 2022-05-25 Kimberly Clark Co Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
MX2018013276A (en) 2016-05-26 2019-03-28 Kimberly Clark Co Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface.
CN113045698B (en) * 2019-12-27 2024-02-06 黄石市森尔新型材料有限公司 Zwitterionic polymer and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9611364D0 (en) 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US9056125B2 (en) * 2004-05-17 2015-06-16 Florida State University Research Foundation, Inc. Films for controlled cell growth and adhesion
JP6085075B2 (en) * 2005-08-25 2017-02-22 ユニヴァーシティ オブ ワシントン Ultra-low fouling sulfobetaine and carboxybetaine materials and related methods

Also Published As

Publication number Publication date
US9254255B2 (en) 2016-02-09
US8980232B2 (en) 2015-03-17
US20150150781A1 (en) 2015-06-04
TWI428150B (en) 2014-03-01
US20120128600A1 (en) 2012-05-24

Similar Documents

Publication Publication Date Title
US10500138B2 (en) Polyphenols/PEG based hydrogel system for a dental varnish
CN111148499B (en) Antimicrobial particles and methods of use thereof
US9254255B2 (en) Dental care product with two-part formulations and utility thereof
RU2727515C2 (en) Compositions for oral care
BR112020017915A2 (en) DECOMPOSITIONS FOR ORAL TREATMENT TO PROMOTE HEALTH OF THE GUMS
JPH02288819A (en) Antiplaque antimicrobial composition for mouth
JP2021516688A (en) Oral care composition to promote gingival health
BR112020017909B1 (en) COMPOSITIONS FOR ORAL TREATMENT TO PROMOTE GINGIVAS HEALTH
BRPI0717922B1 (en) oral care products, method of sending a mesoporous calcium silicate biomaterial to the teeth and use of a mesoporous calcium silicate biomaterial and a matrix of polymeric material in the manufacture of an oral care product
US20220378668A1 (en) Dental varnish
TWI532504B (en) Paraben-free preservative systems for oral care compositions
JP2019218378A (en) Protection of materials by sphingosine based compounds
RU2727969C1 (en) Compositions for oral care
JP2024015364A (en) Anti-stain oral care composition
CN111432780A (en) Oral care compositions
AU2013407588A1 (en) Methods of treating gingivitis using high salt toothpaste
JP7411788B2 (en) Oral care composition comprising a source of stannous ions, a neutral amino acid, and a polyphosphate
Mitwalli Development of New Formulations of nCaF2 Dental Nanocomposites with Antibacterial and Remineralizing Properties
US20150147368A1 (en) Oral mouth rinse
JPS5988416A (en) Oral sanitary composition